Bifidobacterium longum subsp. infantis (B. infantis) is associated with improved growth, the development of intestinal membrane integrity, and is critical for developing immune function.*
The Developing Intestinal Microflora of Newborns Is Up to 90% B. Infantis
B. infantis is the predominant intestinal organism found in breast-fed infants.* B. infantis M-63 was isolated from a healthy infant and clinically shownto colonize the intestines of infants.*
B. infantis is the only bacterial species able to take up and metabolize all Human Milk Oligosaccharides (HMOs) which allows B. infantis to outcompete other bacterial species.*
Jarro-Dophilus Infant is formulated with Medium Chain Triglycerides (MCTs), which are naturally present in breast milk and are more easily absorbed by the newborn�s immature digestive system.*
Serving Size: 10 Drop | Servings Per Container: 30 | ||
| Amount Per Serving | % Daily Value | ||
| Bifidobacterium longum subsp. infantis M-63 1 Billion Viable Cells | 12.5mg | ||
Other ingredients: |
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
